Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Understanding Uganda's drug safety regulations

Dr Kennedy Odokonyero - PHV LATAM/IntuVigilance, Kampala, Uganda

Understanding Uganda's drug safety regulations ( Dr Kennedy Odokonyero - PHV LATAM/IntuVigilance, Kampala, Uganda )

Advances in pharmacovigilance in Nigeria

Dr Elemuwa Uchenna G - Pharmacovigilance National Agency for Food and Drug...

Advances in pharmacovigilance in Nigeria ( Dr Elemuwa Uchenna G - Pharmacovigilance National Agency for Food and Drug Administration and Control (NAFDAC), Abuja, Nigeria )

Understanding pharmacovigilance in Kenya

Dr Dorothy Aywak - Kenyatta National Hospital, Nairobi, Kenya

Understanding pharmacovigilance in Kenya ( Dr Dorothy Aywak - Kenyatta National Hospital, Nairobi, Kenya )

Understanding pharmacovigilance in Namibia

Chelsea Moller - Namibia Medicines Regulatory Council (NMRC), Windhoek, Namibia

Understanding pharmacovigilance in Namibia ( Chelsea Moller - Namibia Medicines Regulatory Council (NMRC), Windhoek, Namibia )

Advancements in pharmacovigilance in East Africa

Felix Mochache - Novartis, Nairobi, Kenya

Advancements in pharmacovigilance in East Africa ( Felix Mochache - Novartis, Nairobi, Kenya )

Understanding Rwanda's FDA and its role in medicine regulation

Dr Lazare Ntirengenya - Rwanda Food and Drugs Authority (Rwanda FDA), Kigali...

Understanding Rwanda's FDA and its role in medicine regulation ( Dr Lazare Ntirengenya - Rwanda Food and Drugs Authority (Rwanda FDA), Kigali, Rwanda )

Understanding the role of the Tanzania Medicines and Medical Devices Authority

Damas Matiko - Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma...

Understanding the role of the Tanzania Medicines and Medical Devices Authority ( Damas Matiko - Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania )

A checklist for designing and reporting cancer drug phase 3 clinical trials

Dr Bishal Gyawali - Queen's University, Kingston, Canada

A checklist for designing and reporting cancer drug phase 3 clinical trials ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

Blood-based test may provide a convenient and effective option for CRC...

Dr Aasma Shaukat - NYU Grossman School of Medicine, New York, USA

Blood-based test may provide a convenient and effective option for CRC screening in the average-risk U.S. population ( Dr Aasma Shaukat - NYU Grossman School of Medicine, New York, USA )

Everolimus plus lanreotide might be a new standard treatment in the first-line...

Dr Susumu Hijioka - National Cancer Center Hospital, Chuo City, Japan

Everolimus plus lanreotide might be a new standard treatment in the first-line setting for grade 1/2 GEP-NETs ( Dr Susumu Hijioka - National Cancer Center Hospital, Chuo City, Japan )

Gemcitabine/nab-paclitaxel compared with 5-fluorouracil/leucovorin/liposomal...

Dr Efrat Dotan - University of Pennsylvania, Philadelphia, USA

Gemcitabine/nab-paclitaxel compared with 5-fluorouracil/leucovorin/liposomal irinotecan shows similar results in older patients ( Dr Efrat Dotan - University of Pennsylvania, Philadelphia, USA )

Radiotherapy in Kharkiv

Dr Sergii Artiukh - National Academy of Sciences of Ukraine, Kyiv, Ukraine

Radiotherapy in Kharkiv ( Dr Sergii Artiukh - National Academy of Sciences of Ukraine, Kyiv, Ukraine )

More from ecancer